CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is among the 10 Stocks That Could Skyrocket in 2026. On February 27, Jefferies ...

Liberty Lake, WA, March 05, 2026 (GLOBE NEWSWIRE) -- TorchLight, a managed cybersecurity services provider, today announced its approval as an authorized vendor through two major cooperative ...

March should be an interesting month for one stock in particular, SentinelOne (NYSE: S). The cybersecurity stock has ...

One platform for KYC, anti-fraud, and geolocation--purpose-built for Brazil, engineered to maximize conversion from day one. VANCOUVER, British Columbia & RIO DE JANEIRO--(BUSINESS WIRE)--March 04, ...

An August 2025 ransomware attack on the University of Hawaii Cancer Center's epidemiology division has affected 1.2 million ...

Good morning, and welcome to Ocugen's Fourth Quarter and Full Year 2025 Financial Results and Business Update [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head ...

The Moroccan cybersecurity sector is poised for a significant surge, with its market value projected to climb from $144.57 million in 2025 to $238.12 million by 2031.

Live Updates Here's What Wall Street Asked About on CrowdStrike's Earnings Call Mar 3, 2026 at 6:22 PM EST CrowdStrike (CRWD) shares are down about .5% after their conference call concluded tonight.

Phase 3 CYPRESS study did not meet the primary endpoint, the OHSA Composite Score, a patient reported outcome (PRO) Cash of $326.5 million at Q4 2025 (no debt); ...

PYRUKYND is the only medicine approved in the UAE for adults with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia NewBridge Pharmaceuticals, a regional specialty company ...

Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001) in new analysis with adjustment for ...

Q4 2025 Management View CEO John Pagliuca reported, "We entered 2026 with momentum, following another year of profitable growth and with confidence that we can drive continued strong performance." He ...